Company Expects to Achieve Approximately $100 Million in Cost Savings Over the Next 12 Months* While Continuing to Invest in European Launches and Global Expansion --
-- Reduces U.S. Commercial Organization by Ninety Percent of Pre-Pandemic / Pre-Generic Competition Levels --
-- Creates Core Focused U.S. Commercial Team to Support Branded VASCEPA Revenues --
-- Actions Optimize Operations While Maintaining Positive U.S. Contribution Margin to Support Company’s Next Steps --
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.